ByTy Roush,
Forbes Staff.
Eli Lilly on Monday lowered the cost of Zepbound after the pharmaceutical giant and Ozempic maker Novo Nordisk announced a deal with the Trump administration to slash the prices of the popular weight-loss drugs.
The out-of-pocket monthly price for the lowest single-dose vial of Zepbound is now $299 when purchased through Eli Lilly’s platform LillyDirect, a 14% decrease from $349, while the 5-milligram dose was cut to $399, a roughly 20% cut from $499, Eli Lilly announced.
Prices for the 7.5 through 15 milligram doses were reduced to $449 from $499.
